Location History:
- Otsu, JP (2009)
- Shiga, JP (2014)
Company Filing History:
Years Active: 2009-2014
Title: Innovations by Yasushi Katayama
Introduction
Yasushi Katayama is a prominent inventor based in Shiga, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of retrovirus storage and production. With a total of 2 patents to his name, Katayama's work has implications for gene therapy and viral vector production.
Latest Patents
Katayama's latest patents include a method of retrovirus storage and a serum-free medium for producing retroviruses. The first patent describes a method characterized by sustaining a retrovirus in the presence of a substance with retrovirus binding activity immobilized on a solid phase. This innovation allows for the retrovirus to be sealed in a container that holds the solid phase, enhancing its storage capabilities. The second patent provides a method for obtaining a virus vector free of serum, along with a serum-free medium for cultivating virus producer cells. This medium, which contains serum albumin, enables the cultivation of cells in a manner equivalent to serum-containing mediums, resulting in a virus vector with gene transfer efficiency comparable to conventional vectors. These advancements are particularly useful for gene therapy and related studies.
Career Highlights
Yasushi Katayama is associated with Takara Bio Inc., a company known for its focus on biotechnology and life sciences. His work at the company has allowed him to explore innovative solutions in the field of retroviruses and gene therapy.
Collaborations
Katayama has collaborated with notable coworkers such as Junichi Mineno and Ikunoshin Kato. Their combined expertise contributes to the advancement of research and development in biotechnology.
Conclusion
Yasushi Katayama's contributions to the field of biotechnology through his patents and work at Takara Bio Inc. highlight his role as an influential inventor. His innovations in retrovirus storage and production are paving the way for advancements in gene therapy and viral vector applications.